Prosecution Insights
Last updated: November 04, 2026

Gerhard Gries

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Gerhard Gries has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, VIGIL, TORIANA NICHOLE, in a single art unit. The prosecution profile is currently limited to this 1 pending office action, making it the central focus of the patenting efforts.

All current activity is focused on resolving this single matter within the specified unit. VIGIL, TORIANA NICHOLE is the busiest examiner, managing this 1 pending office action. Practitioners should focus on the specific requirements of the 1 distinct art unit to ensure a successful outcome. Because there is only a single active case, the entire portfolio's status depends on the resolution of this matter. This concentration allows for a very targeted approach to the prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VIGIL, TORIANA NICHOLE 1 52.9% +26.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19042407 LETHAL BAIT FOR PEST ANT CONTROL VIGIL, TORIANA NICHOLE —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19042407 LETHAL BAIT FOR PEST ANT CONTROL VIGIL, TORIANA NICHOLE —

Top Art Units

Art UnitApps
1612 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19042407 LETHAL BAIT FOR PEST ANT CONTROL VIGIL, TORIANA NICHOLE 1612 §102§103 Non-Final OA — Pending Jan 31, 2025

Managing Gerhard Gries's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Gerhard Gries have?

Gerhard Gries has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Gerhard Gries applications?

Toriana Nichole Vigil has the most, with 1 of Gerhard Gries's pending office actions.

What technology area are Gerhard Gries's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month